Professional Documents
Culture Documents
H O S T E D BY
Available online at www.sciencedirect.com
ScienceDirect
j o u r n a l h o m e p a g e : w w w. e l s e v i e r. c o m / l o c a t e / a j p s
Short Communication
A R T I C L E I N F O A B S T R A C T
Article history: This work evaluates intercalation of Nortriptyline (NT) and Venlafaxine (VFX) in an interlayer
Received 20 April 2015 gallery of Na+-MMT (Montmorillonite), which was further compounded with Poly (L-
Received in revised form 2 June Lactide) (PLLA) to form microcomposite spheres (MPs) for oral controlled drug delivery. The
2015 XRD patterns, thermal and spectroscopic analyses indicated intercalation of drugs into the
Accepted 24 June 2015 MMT interlayer that was stabilized by electrostatic interaction. No significant changes in
Available online 9 July 2015 structural and functional properties of drugs were found in the MMT layers. In vitro drug
release studies showed controlled release pattern.
Keywords: © 2015 The Authors. Production and hosting by Elsevier B.V. on behalf of Shenyang Phar-
Nortriptyline maceutical University. This is an open access article under the CC BY-NC-ND license
Venlafaxine (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Poly (L-Lactide)
Montmorillonite
Antidepressant
* Corresponding author. Institute of Science, Nirma University, Ahmedabad 382481, Gujarat, India. Tel.: +91 2717 241900 to 04, +91 2717
241911 to 15; fax: + 91 2717 241916 17.
E-mail address: shalini.rjk@nirmauni.ac.in (S. Rajkumar).
** Corresponding author. Discipline of Inorganic Materials and Catalysis, Central Salt and Marine Chemicals Research Institute, Council
of Scientific and Industrial Research (CSIR), Gijubhai Badheka Marg, Bhavnagar 364 021, Gujarat, India. Tel.: +91 278 2471793; fax: +91 278
2567562.
E-mail address: hcbajaj@csmcri.org (H.C. Bajaj).
Peer review under responsibility of Shenyang Pharmaceutical University.
http://dx.doi.org/10.1016/j.ajps.2015.06.002
1818-0876/© 2015 The Authors. Production and hosting by Elsevier B.V. on behalf of Shenyang Pharmaceutical University. This is an
open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
asian journal of pharmaceutical sciences 10 (2015) 452–458 453
Therefore, there is a need to prepare formulations for the con- the filtrates were measured by UV absorbance at λmax = 236 nm
trolled and safe release of drugs, which may be done by using for NT and λmax = 224 nm for VFX using UV-visible spectropho-
clay-based materials. tometer UV 2550 (Shimadzu, Japan), equipped with a quartz
The design of effective, controlled drug delivery systems to cell having a path length of 1 cm. All the intercalation studies
circumvent the problem of high drug clearance rates is an were performed in triplicates, and the values were averaged
ongoing challenge. One strategy is the use of layered silicate for data analysis.
material-based delivery systems, consisting of layered struc-
ture constructed from tetrahedrally coordinated silica atoms
2.3. Preparation of micro composite spheres
fused into an edge-shared octahedral plane of aluminum-
based nanosheets like assemblies, such as Montmorillonite The micro composite spheres (MPs) were prepared with the
(MMT), for intercalation of a wide range of toxic drugs. Montmo- oil in water (o/w) solvent evaporation method. Two grams of
rillonite (MMT) is one of the most commonly used medical clay PLLA was dissolved in 100 ml dichloromethane and soni-
that consists of a lamellar stack of crystalline, 1 nm thick alu- cated for 20 min, to which NT–MMT hybrid (PLLA:NT–
minosilicate sheets. Naturally occurring cations (i.e., Na+) reside MMT = 1:0.5% w/w) was added and further sonicated for 10 min
between the sheets to balance the overall negative surface followed by stirring for 1 h. The organic phase was added drop
charge of the MMT. In water, the lamellar stack swells, pro- wise (0.5 ml/min) into the external aqueous phase contain-
ducing an electrostatically stabilized dispersion of nanoscale ing 0.5% w/v of polyvinyl alcohol (500 ml) with stirring until
sheets. The ion exchange capacity of MMT enables the re- dichloromethane evaporation. The microcomposite particles
placement of Na+ with other organic and inorganic cations to were collected using filter paper, washed 5 times with Milli-Q
add functionality, spurring research into the use of MMT. Overall, water and resuspended in 25 ml Milli-Q water, frozen in liquid
the ion exchange nature and biocompatibility of clays make nitrogen and lyophilized. The samples were designated as NMPs,
them versatile carrier for many vital drugs [8–14]. and the same methods of preparation followed for VFX with
Here we report a method for preparation and characteriza- samples were designated as VMPs.
tion of NT and VFX loaded layered silicates, Montmorillonite
(MMT) (drug–clay hybrids) and further compounding in PLLA
to form microcomposite spheres (MPs), XRD, TGA, FT-IR and 2.4. Characterization
SEM characterizations and their potential applications in drug
delivery. The in vitro release characteristics and release kinet- X-ray diffraction (XRD) analysis was carried out on Phillips
ics models are also presented. powder diffractometer X’ Pert MPD using PW3123/00 curved
Ni-filtered Cu-Kα radiation with a scanning of 0.3°/min in 2θ
range of 2–10°. Fourier transform infrared spectra (FT-IR) were
recorded on Perkin-Elmer, GX-FTIR as KBr pellet in 4000–
2. Materials and methods 400 cm−1 range. Thermo gravimetric analysis (TGA) was carried
out within 30–800 °C at the heating rate 10 °C/min under ni-
2.1. Materials trogen flow (20 ml/min) using TGA/SDTA 851e (Mettler-
Toledo, Switzerland). The particle size distributions were mea-
For the present study, sodium MMT (Cloisite Na+) was given sured with the Zeta sizer-Nano-ZS90, Nano Series (Malvern
by Southern Clay Products Incorporation, USA. Poly (L-Lactide) Instruments Ltd., Malvern, UK). The morphology of pristine
(PLLA) with MW of 152,000 (inherent viscosity: 2.0 d/g), cellu- MMT, NT/VFX intercalated MMT and microcomposite par-
lose acetate dialysis tube (MW: 07014), nortriptyline ticles (MPs) was observed by scanning electron microscope
hydrochloride were from Sigma–Aldrich, USA, and Venlafaxine (SEM), LEO-1430VP, UK. The UV-visible absorbance of drug so-
(VFX) was obtained as a gift sample from Lupin Pharmaceu- lutions was measured using UV-visible spectrophotometer
ticals Ltd (India). PVA, Mw. 1, 25,000 were purchased from S.D. UV2550 (Shimadzu, Japan), equipped with a quartz cell having
Fine Chemicals Pvt. Ltd. All the other HPLC reagents were used a path length of 1 cm.
as received. Millipore water was prepared by a Milli-Q plus
system (Millipore Corporation, USA).
2.5. In vitro release behavior of drugs
2.2. Drug–clay hybrids preparation In vitro release of drug was carried out in Julabo shaking water
bath (SW23) using a buffer solution of pH 7.4 (simulated in-
For preparing the drug–clay hybrids, 2 g MMT was vigorously testinal fluid) as release medium. In brief, precise amounts of
stirred in 100 ml of Milli-Q water for 1 h. Two grams of NT so- pristine NT/VFX, NT/VFX–MMT hybrid and MPs were im-
lution (2 wt. % in Milli-Q water) was added drop wise (2 ml/min) mersed in cellulose acetate dialysis tube and set in flasks
into the suspension of MMT within 1 h at room temperature containing 150 ml release medium. The temperature was main-
using peristaltic pump (Master flex L/S 7518-00, Cole–Parmer, tained at 37 ± 0.5 °C with the shaking frequency at 100 rpm.
USA). The mixed solution was further stirred (800 rpm) for 24 h, One milliliter aliquots were withdrawn at regular time inter-
filtered, washed several times with water to remove the non- val, and the same volume was restored with fresh release
intercalated NT, dried at 60 °C, and ground with mortar and medium. Samples were analyzed by HPLC in triplicates, and
pestle to obtain fine powder. This sample was designated as the average values were used in data analysis. The release be-
NT–MMT hybrid. The same method was followed for VFX– havior of the drug from the NT–MMT and MPs was fitted
MMT preparation. The remaining concentrations of drugs in in Higuchi, Korsmeyer–Peppas, Elovich equation, parabolic
454 asian journal of pharmaceutical sciences 10 (2015) 452–458
diffusion, Bhaskara equation, and modified-Freundlich kinetic driving force for the cationic drugs intercalation. The NT and
models [12–14]. VFX intercalation course was mainly controlled by cationic ex-
change mechanism due to the Coulombic interaction between
2.6. Drugs quantification by HPLC the positive amine groups of both the drugs and the posi-
tively charged sodium ions present in the interlayer gallery of
The quantification of drug from release media was deter- MMT layers.
mined by using a validated HPLC method. Briefly, subsequent
to the preparation of samples, analysis by high-performance
3.2. The drugs intercalation in MMT confirmation
liquid chromatography (HPLC) system consisting of photodi-
ode array detector (Waters Alliance model: 2695 separation
3.2.1. X-ray diffraction
module with Waters 2996 Photo Diode Array Detector, Waters
The XRD was used for the investigation of structural change
Corporation, Milford, MA, USA) and a reverse-phase C18 column
of MMT lattice. Fig. 1[A] shows the XRD patterns of pristine
(for NT: Waters X’Bridge TM C18 HPLC column with
MMT, NT–MMT and MPs. The XRD of MMT exhibited broad-
length = 100 mm, ID = 2.1 mm, particle size = 5.0 µm, Waters Cor-
ened peak at 2θ = 8.0°. The broadened peak reflected the fine
poration, Milford, MA, USA; and for VFX: Phenomenex® make
particle size of MMT. After intercalation of drugs, the peak
Luna C18 (2) HPLC column with length = 25 cm, ID = 4.6 mm,
shifted from 8.0° to 5.8°–5.9°. The XRD results confirmed suc-
particle size = 5.0 µm, Phenomenex Inc, Torrance, CA, USA) was
cessful intercalation of drug into the interlayer space of MMT
carried out. Drug-containing samples were transferred to auto
and increased basal spacing of silicate interlayer. The d-spacing
sampler vials, capped and placed in cassettes of the HPLC auto
of basal planes of NT/VFX–MMT with 1.5 to 1.45 nm signifi-
sampler. The mobile phase employed for NT analysis was the
cantly increased from the initial value of 1.1 nm in MMT.
mixture of 0.05 M KH2PO4 buffer (pH 3.0 ± 0.05) and acetoni-
However, the intensity of the XRD characteristic peak in-
trile (50:50% w/v). The injection volume was 10 µl with flow
creased in drug-loaded MMT, which indicated an impervious
0.1 ml/min, and detection wavelength (λmax) was set at 240 nm,
ordering of sheet structure caused by cation exchange and
while the mobile phase employed for VFX analysis was the
higher restoration of charge density during drug loading. The
mixture of 0.025 M potassium dihydrogen phosphate (pH: 3.3,)-
chemical structures of NT and VFX are shown in Fig. 1[B], and
acetonitrile (60:40 v/v). The injection volume was 10 µl with flow
2–80° scanning XRD data are presented in supplementary ma-
1 ml/min, and detection wavelength (λmax) for VFX was at
terial as Fig. S1.
225 nm. The drug concentration in samples was determined
using the standard curve obtained for known concentrations
of NT and VFX in release medium processed similarly 3.2.2. FT-IR spectroscopy
(r2 = 0.9996–0.9999). The FT-IR spectra of the drugs-loaded clay hybrid NT/VFX–
MMT and MPs were compared with that of the pristine MMT
and NT/VFX (Fig. 2). The spectrum of MMT revealed the char-
3. Results and discussion acteristic absorption bands [12–14]. Pristine NT displayed
characteristic absorption bands of aromatic C=C (1592 cm−1)
3.1. The chemistry of NT intercalation in interlayer and aromatic C—H (2945 cm−1) stretch vibrations; peaks at
gallery of Na+-MMT 3400 cm−1 and 608 cm−1 were indicative of a secondary amine
moiety and the C—N—C scissors vibrations, respectively.
The ionic exchange reaction between the amine groups (-NH2) Pristine VFX had absorption band at 3347 cm−1, which corre-
and sodium ions (≡Si—O−—Na+) in the layered MMT is the main sponded to the stretching vibrations of hydroxyl group and
[A] [B]
125 MMT
NT-MMT
VFX-MMT
100
Intensity (cps)
75
50
25
0
2 4 6 8 10
2θ
Fig. 1 – [A] XRD patterns of pristine MMT and drugs loaded MMT and [B] chemical structures of the drugs.
asian journal of pharmaceutical sciences 10 (2015) 452–458 455
1µm
Bi Bii
1µm 2µm
Ci Cii
2µm 2µm
Fig. 3 – SEM images of [A] pristine MMT, [Bi] NT–MMT hybrid, [Bii] NT–MMT hybrid, [Ci] NMPs and [Cii] VMPs.
40
MMT
NT-MMT
35 VFX-MMT
30
Intensities(%)
25
20
15
10
5
0
0 1000 2000 3000 4000
Size (d. nm) Fig. 5 – In vitro release profiles of drugs in simulated
intestinal fluid (pH 7.4) at 37 ± 0.5 °C; data represent mean
Fig. 4 – Particle size distribution. of n = 3.
asian journal of pharmaceutical sciences 10 (2015) 452–458 457
Table 1 – Linear correlation coefficient (r2) and rate constant (K) of the diffusion kinetic models applied to drug release
from NT/VFX–MMT and MPs (release data were considered from first 24 h at pH 7.4).
Kinetic models Parameters Formulations
NT–MMT NMPs VFX–MMT VMPs
2
Higuchi-equation r 0.9172 0.9623 0.8388 0.9331
KH 6.3487 1.6492 8.9170 1.7149
Korsmeyer–Peppas r2 0.9475 0.9852 0.8216 0.8926
n 0.36311 0.3634 0.4567 0.5894
KHP 0.3062 0.2357 0.3131 0.1701
Elovich equation r2 0.9973 0.9789 0.9026 0.9561
KE 3.8772 1.0047 5.0962 0.9618
Parabolic diffusion r2 0.9068 0.9798 0.8388 0.9331
Kp 0.1459 0.1231 0.2370 0.2188
Bhaskara equation r2 0.9168 0.9829 0.8474 0.9248
K −0.0208 −0.0050 −0.0303 −0.0045
Modified-Freundlich r2 0.9206 0.9043 0.9688 0.9528
K −0.5628 −0.3211 −1.120 −0.5477
drug release from the drug–MMT was from flat surface with convenient spectrophotometric method. Rasayan J Chem
heterogeneous sites for ion exchange diffusion process [16–21]. 2009;2:276.
[2] Be Que JC, Montigny CD, Blier P, et al. Venlafaxine:
discrepancy between in vivo 5-HT and NE reuptake blockade
4. Conclusion and affinity for reuptake sites. Synapse 1999;32:198.
[3] Wei Z, Bing-ren X, Cai-yun W. Liquid chromatography–mass
spectrometry method for the determination of venlafaxine
We have successfully intercalated antidepressant agents (NT in human plasma and application to a pharmacokinetic
and VFX) into MMT galleries, and incorporation of PLLA with study. Biomed Chromatogr 2007;21:266.
NT/VFX–MMT hybrids achieved controlled drug release prop- [4] Yildiz A, Gonul AS, Tamam L. Mechanism of actions of
erty. In vitro studies showed release of NT/VFX from MMT/ antidepressants: beyond the receptors. Bull Clin
Psychopharmacol 2002;12:194.
MPs by partial diffusion through a swollen matrix/de-
[5] Park ES, Lee DS, Kwon SY, et al. A new formulation of
intercalation of layers of carriers to its individual components controlled release amitriptyline pellets and its in vivo/in vitro
or nanostructures of different compositions. This simple en- assessments. Arch Pharm Res 2003;26:569.
trapment technology will be valuable in aiding to overcome [6] Melero A, Garrigues TM, Almudevera P, et al. Nortriptyline
burst release of the NT/VFX, and this clay showed great po- hydrochloride skin absorption: development of a
tential to become a new dosage form of NT/VFX, and the transdermal patch. Eur J Pharm Biopharm 2008;69:588.
[7] Manzo RH, Olivera ME, Amidon GL, et al. Biowaiver
methodology can also be applied to other drugs.
monographs for immediate release solid oral dosage forms:
amitriptyline hydrochloride. J Pharm Sci 2006;95:966.
[8] Park JK, Choy YB, Oh JM, et al. Controlled release of
Acknowledgments
donepezil intercalated in smectite clays. Int J Pharm
2008;359:198.
Authors are thankful to Director, CSMCRI, Bhavnagar for pro- [9] Sun B, Ranganathan B, Feng SS. Multifunctional poly(D,
viding necessary infrastructure facilities and the Council of L -lactide-co-glycolide)/montmorillonite (PLGA/MMT)
nanoparticles decorated by Trastuzumab for targeted
Scientific and Industrial Research, Government of India, New
chemotherapy of breast cancer. Biomaterials 2008;29:475.
Delhi, India (CSIR) for Senior research fellowship awarded to [10] Dong Y, Feng SS. Poly(D, L-lactide-co-glycolide)/
BDK, and funding under Network Project: NWP 0010. Authors montmorillonite nanoparticles for oral delivery of
are also thankful for the help and cooperation rendered by Dr. anticancer drugs. Biomaterials 2005;26:6068.
Harshad Brahmbhatt (HPLC), Mr. V. Agarwal (FT-IR), Mr. Jayesh [11] Feng SS, Mei L. Poly(lactide)–vitamin E derivative/
C. Chaudhari (SEM) and Mrs. Sheetal Patel (TGA) of the ana- montmorillonite nanoparticle formulations for the oral
lytical section of the CSMCRI. delivery of Docetaxel. Biomaterials 2009;30:3297.
[12] Kevadiya BD, Joshi GV, Bajaj HC. Layered bionanocomposites
as carrier for procainamide. Int J Pharm 2010;388:280.
[13] Joshi GV, Kevadiya BD, Mody HM, et al. Confinement and
Appendix: Supplementary material
controlled release of quinine on chitosan–montmorillonite
bionanocomposites. J Poly Sci Part A: Poly Chem 2012;
Supplementary data to this article can be found online at 50:423.
doi:10.1016/j.ajps.2015.06.002. [14] Joshi GV, Kevadiya BD, Bajaj HC. Design and evaluation of
controlled drug delivery system of buspirone using
inorganic layered clay mineral. Micropor Mesopor Mater
REFERENCES
2010;132:526.
[15] Shah S, Pal A, Kaushik VK, et al. Preparation and
characterization of venlafaxine hydrochloride-loaded
[1] Rao MVB, Reddy BCK, Srinivasarao T, et al. Estimation of chitosan nanoparticles and in vitro release of drug. J Appl
venlafaxine in commercial dosage forms using simple and Polym Sci 2009;112:2876.
458 asian journal of pharmaceutical sciences 10 (2015) 452–458
[16] Zhang H, Pan D, Zou K, et al. A novel core-shell structured [19] Gu Z, Thomas AC, Xu ZP, et al. In vitro sustained release of
magnetic organic-inorganic nanohybrid involving drug- LMWH from MgAl-layered double hydroxide nanohybrids.
intercalated layered double hydroxides coated on a Chem Mater 2008;20:3715.
magnesium ferrite core for magnetically controlled drug [20] Zhang H, Pan D, Duan X. Synthesis, characterization, and
release. J Mater Chem 2009;19:3069. magnetically controlled release behavior of novel core−shell
[17] Panda HS, Srivastava R, Bahadur D. In-vitro release kinetics structural magnetic ibuprofen-intercalated LDH
and stability of anticardiovascular drugs-intercalated nanohybrids. J Phys Chem C 2009;113:12140.
layered double hydroxide nanohybrids. J Phys Chem B [21] Yang JH, Han YS, Park M, et al. New inorganic-based drug
2009;113:15090. delivery system of indole-3-acetic acid-layered metal
[18] Song SW, Hidajat K, Kawi S. pH-Controllable drug release hydroxide nanohybrids with controlled release rate. Chem
using hydrogel encapsulated mesoporous silica. Chem Mater 2007;19:2679.
Commun 2007;42:4396.